- Identify disease modifying therapies in sickle cell disease
- Demonstrate knowledge of how to use currently available treatments
- Summerize the factors that contribute to the heterogeneity in VTE risk among cancer patients
- Outline the evolving role of the direct oral anticoagulants in treating cancer associated thrombosis
Event address for attendees: https://uwmadison.webex.com/uwmadison/onstage/g.php?MTID=e6e900959d4bd98606809a6144c0ee9fd
Session date:
02/24/2021 - 8:00am to 9:00am CST
Location:
Clinical Science Center, G5/119
600 Highland Ave
Madison, WI
53792
United States
See map: Google Maps
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
Add to calendar:
Discloser List CME Internal Report
Presenter(s):
Dr. John Sheehan
Dr. Moniba Nazeef